Gene · 2249
NIH grants2,054
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 2,054
Download this page as JSON| Grant | Title | FGF4 papers | Newest fiscal year |
|---|---|---|---|
| R01AI080656 | Regulation of Rotavirus Replication | 1 | 2025 |
| R01AI091627 | Notch Signaling in Alloimmunity | 1 | 2025 |
| R01AI118891 | Viral modulation of epitranscriptomic mechanisms | 1 | 2025 |
| R01AR045203 | D4Z4 Coding Transcripts and FSHD | 1 | 2025 |
| R01AR064327 | Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | 1 | 2025 |
| R01CA157644 | Central tolerance mechanisms in B-cell malignancies | 1 | 2025 |
| R01CA163915 | ATP-Dependent Chromatin Remodeling in Human Malignancy | 1 | 2025 |
| R01CA164273 | Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors | 1 | 2025 |
| R01CA190558 | Mechanisms of Serrated Colon Tumor Suppression | 1 | 2025 |
| R01CA215052 | Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and Progression | 1 | 2025 |
| R01CA245514 | The selective advantage of mismatch repair loss in colonic stem cells | 1 | 2025 |
| R01CA250227 | Investigating multifactorial beta-catenin activation in hepatocellular cancers | 1 | 2025 |
| R01CA258867 | Therapeutic targeting of FGF19-driven cancers with FGF21 variants | 1 | 2025 |
| R01DC012049 | Optimizing Genetic Testing for Deafness for Clinical Diagnostics | 1 | 2025 |
| R01DE017914 | Molecular Interactions during Neural Crest Formation | 1 | 2025 |
| R01DK057993 | Pathophysiology of Biliary Disease | 1 | 2025 |
| R01DK062794 | The role of the innate immune cell cyclooxygenase/prostaglandin system in blood pressureregulation | 1 | 2025 |
| R01DK069710 | The Role of Nuclear PARPs in Signal-Regulated Transcription | 1 | 2025 |
| R01DK069921 | The Laminin Receptors in Kidney Disease | 1 | 2025 |
| R01DK071801 | Mass Spectrometric Studies of Neuropeptides in Feeding | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/grants?page=9